Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2015.04.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Epigenetics in Breast Cancer: What's New?

Breast Cancer Research
Cancer ResearchOncology
2011English

Subclinical Cardiotoxicity Following Adjuvant Dose-Escalated FEC, High-Dose Chemotherapy, or CMF in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2000English

Metronomic Chemotherapy in Metastatic Breast Cancer

Novel Research in Sciences
2019English

Leucocyte Nadir as a Marker for Chemotherapy Efficacy in Node-Positive Breast Cancer Treated With Adjuvant CMF

British Journal of Cancer
Cancer ResearchOncology
1999English

Sequential Adriamycin and CMF in Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Adjuvant Medical Treatment for Breast Cancer in Elderly and Old Women

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

CAF vs. CMF Combination Chemotherapy in Advanced Breast Cancer Patients

International Journal of Science and Research (IJSR)
2016English

A Cohort Study of Ethnic Differences in Use of Adjuvant Chemotherapy and Radiation Therapy for Breast Cancer in New Zealand

BMC Health Services Research
Health Policy
2017English

Breast Cancer Biology and Ethnic Disparities in Breast Cancer Mortality in New Zealand: A Cohort Study

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy